GRANULES INDIA LTD.-$ - 532482 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Loss of Certificate / Duplicate Certificate07-11-2022
07-11-2022
Hold Granules India; target of Rs 400: Sharekhan
Sharekhan recommended Hold rating on Granules India with a target price of Rs 400 in its research report dated October 28, 2022.01-11-2022
Buy Granules India; target of Rs 410: ICICI Direct
ICICI Direct is bullish on Granules India recommended buy rating on the stock with a target price of Rs 410 in its research report dated October 25, 2022.27-10-2022
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Earnings Conference call for Q2 of the financial year 2022-2327-10-2022
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of the Earnings Conference call for Q2 of the financial year 2022-2320-10-2022
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Closure of Buy Back
Extinguishment of equity shares under Buyback.20-10-2022
Paracetamol Maker Granules India Quarterly Profit Rises 80%
Pharmaceutical company Granules India Ltd reported an 80% surge in quarterly profit on Thursday, boosted by higher sales of painkiller drug Paracetamol.20-10-2022
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for Q2 results for FY2320-10-2022
GRANULES INDIA LTD.-$ - 532482 - Newspaper Publication For Post-Buyback Public Announcement.
Newspaper publication for Post-buyback public announcement.20-10-2022
GRANULES INDIA LTD.-$ - 532482 - Board Meeting Outcome for Financial Results For The Second Quarter & Half Year Ended On September 30, 2022
Financial Results for the second quarter & Half year ended on September 30, 202220-10-2022